Five Chinese Drugmakers Sign Up to Export Generic Paxlovid

By Zhao Jinzhao, Jiang Moting, Bao Zhiming and Denise Jia

Pfizer won’t receive royalties from sales of Paxlovid in low-income countries.

Five Chinese drugmakers signed agreements with a United Nations-backed organization to produce low-cost generic versions of Pfizer Inc.’s Paxlovid Covid-19 pill for export, the organization announced Thursday.

The companies are Shanghai Desano Pharmaceuticals Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd. (600521.SH), Apeloa Pharmaceutical Co. Ltd. (000739.SZ), Shanghai Fosun Pharmaceutical Co. Ltd. (600196.SH) and Zhejiang Jiuzhou Pharmaceutical Co. Ltd. (603456.SH). They are among 35 global drugmakers lined up by the U.N.-backed group to supply generic Paxlovid for poorer countries.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS